AU2020902140A0 - Dextromethorphan-based combination therapies for depressive disorders - Google Patents

Dextromethorphan-based combination therapies for depressive disorders

Info

Publication number
AU2020902140A0
AU2020902140A0 AU2020902140A AU2020902140A AU2020902140A0 AU 2020902140 A0 AU2020902140 A0 AU 2020902140A0 AU 2020902140 A AU2020902140 A AU 2020902140A AU 2020902140 A AU2020902140 A AU 2020902140A AU 2020902140 A0 AU2020902140 A0 AU 2020902140A0
Authority
AU
Australia
Prior art keywords
dextromethorphan
combination therapies
depressive disorders
based combination
depressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020902140A
Inventor
William Murray Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forest Co Pty Ltd
Original Assignee
Forest Co Pty Ltd
Filing date
Publication date
Application filed by Forest Co Pty Ltd filed Critical Forest Co Pty Ltd
Publication of AU2020902140A0 publication Critical patent/AU2020902140A0/en
Pending legal-status Critical Current

Links

AU2020902140A 2020-06-26 Dextromethorphan-based combination therapies for depressive disorders Pending AU2020902140A0 (en)

Publications (1)

Publication Number Publication Date
AU2020902140A0 true AU2020902140A0 (en) 2020-07-09

Family

ID=

Similar Documents

Publication Publication Date Title
EP3692158A4 (en) Gene therapies for lysosomal disorders
EP3890716A4 (en) Combination therapies
EP3799680A4 (en) Configured grant operation
EP3773572A4 (en) Rimegepant for cgrp related disorders
EP3692075A4 (en) Gene therapies for lysosomal disorders
EP3692151A4 (en) Gene therapies for lysosomal disorders
EP4034123A4 (en) Combination therapies
EP3849535A4 (en) Combination therapies
EP3930851A4 (en) Combination therapies
IL286901A (en) Gene therapies for lysosomal disorders
EP3927496A4 (en) Actuator for physical therapy
EP3810781A4 (en) Gene therapy for cns degeneration
EP3860609A4 (en) Combination therapies
EP3849538A4 (en) Combination therapies
EP3849536A4 (en) Combination therapies
EP3773629A4 (en) Car-treg-based therapies for treating neurodegenerative diseases
EP3849534A4 (en) Combination therapies
EP4045163A4 (en) Activity box
EP3887396A4 (en) Gene therapies for neurodegenerative disease
ZA202212919B (en) Transposition-based therapies
EP3849537A4 (en) Combination therapies
EP3773491A4 (en) Methods for treating apoe4/4-associated disorders
EP3953106A4 (en) Segment designs for discs
IL286903A (en) Gene therapies for lysosomal disorders
EP3976100A4 (en) Combination therapy